Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.

[1]  M. Vannucchi,et al.  Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice , 2011, Journal of liposome research.

[2]  Hyunjin Park,et al.  Study of artemisinin nanocapsules as anticancer drug delivery systems. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[3]  C. Uneke,et al.  Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  A. Martinelli,et al.  Plasmodium chabaudi: efficacy of artemisinin + curcumin combination treatment on a clone selected for artemisinin resistance in mice. , 2008, Experimental parasitology.

[5]  A. Fadda,et al.  Liposomes as Carriers for Verbascoside: Stability and Skin Permeation Studies , 2008 .

[6]  F. Nosten,et al.  Artemisinin-based combination treatment of falciparum malaria. , 2007, The American journal of tropical medicine and hygiene.

[7]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[8]  P. Rangarajan,et al.  Curcumin-Artemisinin Combination Therapy for Malaria , 2006, Antimicrobial Agents and Chemotherapy.

[9]  V. Keshamouni,et al.  Curcumin for malaria therapy. , 2005, Biochemical and biophysical research communications.

[10]  P. Legrand,et al.  Efficacy and Pharmacokinetics of Intravenous Nanocapsule Formulations of Halofantrine in Plasmodium berghei-Infected Mice , 2004, Antimicrobial Agents and Chemotherapy.

[11]  H. Fessi,et al.  Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis , 2003, Annals of tropical medicine and parasitology.

[12]  M. Gabriëls,et al.  Physical and chemical evaluation of liposomes, containing artesunate. , 2003, Journal of pharmaceutical and biomedical analysis.

[13]  B. Ryffel,et al.  Oral artesunate prevents Plasmodium berghei Anka infection in mice. , 2003, Parasitology international.

[14]  P. Bloland.  A contrarian view of malaria therapy policy in Africa. , 2003, The American journal of tropical medicine and hygiene.

[15]  K. Yuen,et al.  Therapeutic equivalence of a low dose artemisinin formulation in falciparum malaria patients , 2003, The Journal of pharmacy and pharmacology.

[16]  M. Detaevernier,et al.  Preparation of beta-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice. , 2002, Journal of pharmaceutical and biomedical analysis.

[17]  S. Apers,et al.  In-vivo antimalarial activity of Cassia occidentalism Morinda morindoides and Phyllanthus niruri , 2001, Annals of tropical medicine and parasitology.

[18]  P. Couvreur,et al.  Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. , 2000, International journal of antimicrobial agents.

[19]  M. Majeed,et al.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.

[20]  L. H. Carvalho,et al.  Antimalarial activity of crude extracts from Brazilian plants studied in vivo in Plasmodium berghei-infected mice and in vitro against Plasmodium falciparum in culture. , 1991, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[21]  D. L. Klayman,et al.  Qinghaosu (artemisinin): an antimalarial drug from China , 1985 .

[22]  W. Peters,et al.  The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. , 1980, Annals of tropical medicine and parasitology.

[23]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.